Clinical Trial

Spanish Registry of Digestive Tumours RETUD

Study acronym: RETUD
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this observational study is to assess the current state of digestive tumours in Spain. By doing so, it seeks to enhance the quality of care, optimize the diagnosis and treatment of digestive tumours, and identify opportunities for improvement that can benefit patients. The study will investigate the epidemiological, biological, and clinical characteristics of digestive tumors diagnosed in patients aged 18 and older across healthcare centres in Spain. It also aims to generate knowledge and scientific evidence for events and situations that may impact on patients with digestive tumours (e.g. COVID-19 coronavirus pandemic). Furthermore, subject to the patient's consent, biological samples may be collected for use in translational research projects and for the identification of molecular markers that may be useful in healthcare decision-making.
Trial Details
NCT Number NCT06711211
Lead Sponsor Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Conditions Digestive Cancers, Bile Duct Cancer, Hepatocellular Cancer (HCC), Colorectal Cancer (CRC), Pancreatic Cancer, Rectal Cancer
Enrollment 20,000 participants
Start Date 2020-12-23
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-02